Observational studyPLoS biology2022

Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.

Idoia Busnadiego et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.